Samyang Biopharm Corporation (KRX:0120G0)
South Korea · Delayed Price · Currency is KRW 49,150
-1,950 (-3.82%)
Last updated: Jun 30, 2026, 2:13 PM KST
Samyang Biopharm Market Cap
Samyang Biopharm has a market cap or net worth of 366.22 billion as of June 30, 2026.
Market Cap
366.22B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
49,150.00
Market Cap Chart
Since November 24, 2025, Samyang Biopharm's market cap has increased from 224.56B to 366.22B, an increase of 63.08%. That is a compound annual growth rate of 126.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 30, 2026 | 366.22B | -6.19% |
| Dec 30, 2025 | 390.38B | 73.84% |
| Nov 24, 2025 | 224.56B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| G2GBIO | 595.63B |
| HEM Pharma | 299.61B |
| ImmuneOncia Therapeutics | 291.16B |
| NOVAREX | 199.55B |
| CellBion | 192.29B |
| DAE HWA Pharmaceutical | 153.62B |
| Vivozon Pharmaceutical | 149.81B |
| High Tech Pharm | 135.15B |